Air Liquide enters into exclusive negotiations with Hivest Capital Partners to sell CRYOPDP

Paris, France, March 2, 2020

Air Liquide announced today it has entered into exclusive negotiations with French private equity firm Hivest Capital Partners for the divestment of its subsidiary CRYOPDP.

This decision illustrates Air Liquide’s strategy to regularly review its asset portfolio in order to focus on key businesses and geographies so as to maximize its performances.

This transaction is subject to the signature of a final and definitive agreement between the parties, and will be carried out in the framework of the relevant social processes and ongoing dialogue with the employee representatives’ bodies.

One of the top leaders in its field, CRYOPDP aims to improve the health of people around the world by providing global innovative temperature-controlled logistics solutions to the Clinical Research and Cell & Gene Therapy Communities. With headquarters in France, CRYOPDP has more than 250 employees in 12 countries and operates in more than 150 countries.